
    
      To observe the etiology, diagnosis, management and prognosis of cavernous transformation of
      portal vein.

      We perform Montelukast (10mg, q.d., p.o.) fot the treatment of symptomatic cavernous
      transformation of portal vein and to observe the efficacy such as the decrease of the volume
      of ascites and hydrothorax.
    
  